115 related articles for article (PubMed ID: 36084910)
1. Coumestrol as a new substance that may diminish lipid precursors of the inflammation in steatotic primary rat hepatocytes.
Bzdęga W; Żywno H; Kołakowski A; Kurzyna PF; Harasim-Symbor E; Chabowski A; Konstantynowicz-Nowicka K
Biochimie; 2023 Jan; 204():78-91. PubMed ID: 36084910
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes.
Zywno H; Bzdega W; Kolakowski A; Kurzyna P; Harasim-Symbor E; Sztolsztener K; Chabowski A; Konstantynowicz-Nowicka K
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33673122
[TBL] [Abstract][Full Text] [Related]
3. Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model.
Lee S; Son B; Jeon J; Park G; Kim H; Kang H; Youn H; Jo S; Song JY; Youn B
Cell Physiol Biochem; 2018; 47(6):2233-2249. PubMed ID: 29975946
[TBL] [Abstract][Full Text] [Related]
4. Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro.
Mahli A; Seitz T; Beckröge T; Freese K; Thasler WE; Benkert M; Dietrich P; Weiskirchen R; Bosserhoff A; Hellerbrand C
Cells; 2019 May; 8(5):. PubMed ID: 31096638
[TBL] [Abstract][Full Text] [Related]
5. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
6. Urea cycle dysregulation in non-alcoholic fatty liver disease.
De Chiara F; Heebøll S; Marrone G; Montoliu C; Hamilton-Dutoit S; Ferrandez A; Andreola F; Rombouts K; Grønbæk H; Felipo V; Gracia-Sancho J; Mookerjee RP; Vilstrup H; Jalan R; Thomsen KL
J Hepatol; 2018 Oct; 69(4):905-915. PubMed ID: 29981428
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
Tang Y; Bian Z; Zhao L; Liu Y; Liang S; Wang Q; Han X; Peng Y; Chen X; Shen L; Qiu D; Li Z; Ma X
Clin Exp Immunol; 2011 Nov; 166(2):281-90. PubMed ID: 21985374
[TBL] [Abstract][Full Text] [Related]
8. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
9. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
10. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
11. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
[TBL] [Abstract][Full Text] [Related]
12. [Effect of carnosine and α-lipoic acid on hepatocyte apoptosis and the cytokine profile in induced fatty liver disease in Wistar rats].
Trushina EN; Riger NA; Mustafina OK; Timonin AN; Aksenov IV; Guseva GV; Tutelyan VA
Vopr Pitan; 2020; 89(5):6-16. PubMed ID: 33211913
[TBL] [Abstract][Full Text] [Related]
13. Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation.
Diehl KL; Vorac J; Hofmann K; Meiser P; Unterweger I; Kuerschner L; Weighardt H; Förster I; Thiele C
Cells; 2020 Oct; 9(10):. PubMed ID: 33050035
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
15. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
[TBL] [Abstract][Full Text] [Related]
16. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
[TBL] [Abstract][Full Text] [Related]
17. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.
Chavez-Tapia NC; Rosso N; Tiribelli C
BMC Gastroenterol; 2012 Mar; 12():20. PubMed ID: 22380754
[TBL] [Abstract][Full Text] [Related]
18. The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.
Yu HM; Chung HK; Park KS
Biochem Biophys Res Commun; 2021 Jun; 558():57-63. PubMed ID: 33895552
[TBL] [Abstract][Full Text] [Related]
19. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.
Ganji SH; Kashyap ML; Kamanna VS
Metabolism; 2015 Sep; 64(9):982-90. PubMed ID: 26024755
[TBL] [Abstract][Full Text] [Related]
20. Effect of fructose and 3,5-diiodothyronine (3,5-T(2)) on lipid accumulation and insulin signalling in non-alcoholic fatty liver disease (NAFLD)-like rat primary hepatocytes.
Gnocchi D; Massimi M; Alisi A; Incerpi S; Bruscalupi G
Horm Metab Res; 2014 May; 46(5):333-40. PubMed ID: 24816759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
